Legal Notice and Site Operator | Heyoga

The Onset and Duration of 5 mg Cialis Effects

Cialis > 5 mg of cialis


(We have a comparison of Cialis/Tadalafil vs Viagra/Sildenafil here.) For patients dealing with an enlarged prostate, it’s important to understand that any erectile benefits from a low-dose daily Tadalafil pill will be modest. While it may help manage symptoms of BPH and mild ED, most patients will benefit from exploring the full range of treatment options so that expectations remain realistic and long-term outcomes are optimized. At Georgia Urology, your options run the gamut – from pharmaceutical therapies and minimally invasive procedures that take just a few minutes to more extensive surgical interventions when appropriate. We’ve also recently opened a state-of-the-art IR center specializing in Prostatic Artery Embolization (PAE), one of the most promising non-surgical treatments for an enlarged prostate.

Aspect Details Notes
Recommended Dose 5 mg once daily For erectile dysfunction (ED)
Max Daily Dose 5 mg Do not exceed this dose
Onset of Action 30-60 minutes Varies by individual
Duration of Effect Up to 36 hours Longer than other ED meds
Common Side Effects Headache, flushing, upset stomach Usually mild

The best way to make informed decisions is by consulting with a men’s health urologist who can tailor a plan to your specific needs. Modern urology has never been as advanced as it is today, with new procedures and options for virtually every man. Contact us and schedule an appointment to learn more. To evaluate the safety and effectiveness of daily 5-mg tadalafil treatment for men who have erectile dysfunction (ED) and premature ejaculation (PE), and to assess the long-term follow-up for ED and PE improvement persistence years after the cessation of medication. A prospective, single-blind, randomised study included 160 patients with ED and PE. All were evaluated using the International Index of Erectile Function (IIEF-5) questionnaire to evaluate ED and intravaginal ejaculatory latency time (IELT) for PE. Patients were subdivided into two equal groups. Group I (80 patients) treated with daily 5-mg tadalafil for 3 months, and Group II (80 patients) treated with a placebo for the same period. After 3 months of treatment and 2 years later after cessation of tadalafil, all patients were assessed for ED and PE.

  • The 5 mg dose balances efficacy with side effect profile.
  • Often prescribed after a successful trial of 20 mg as-needed dose.
  • For BPH, it can be combined with an alpha-blocker under supervision.
  • Do not start an alpha-blocker within 4 days of starting Cialis.
  • Can mask symptoms of prostate cancer; regular screenings are key.
  • Not recommended for men with uncontrolled hypertension.
  • Use in men with peptic ulcers or bleeding disorders requires caution.
  • Dehydration or excessive physical activity may increase side effect risk.
  • The decision between daily and on-demand dosing is individualized.
  • Patient assistance programs may be available for financial help.

The mean (SD) IELT and IIEF-5 score pre-treatment were 37 (11.24) s and 13.2 (4.2) for Group I, while in Group II they were 35.98 (10.8) s and 13.12 (4.11), respectively. After 3 months of treatment, the mean (SD) IELT in Group I showed a highly significant improvement from 37 (11.24) s to 120.5 (47.37) s (P < 0.001) but Group II showed no significant improvement from baseline to [39.43 (13.6) s; P > 0.05]. For the IIEF-5 score, there was a highly significant improvement from baseline to 20.45 (4.5) in Group I (P < 0.001), while there was no significant difference in Group II from baseline to [15 (4.84); P > 0.05]. At 2 years after cessation of tadalafil, there was statistically significant improvement in the IELT and IIEF-5 from baseline to endpoint . Oral daily 5-mg tadalafil was effective, tolerable, and safe treatment for patients with ED and PE. Long-term follow-up at 2 years confirmed the persistence of a significant improvement for both ED and PE. Abbreviations: ED: erectile dysfunction; IIEF-5: five-item version of the International Index of Erectile Function questionnaire; IELT: intravaginal ejaculatory latency time; OAD: once-daily; PDE5i: phosphodiesterase-5 inhibitors; PE: premature ejaculation; PRN: pro re nata Erectile dysfunction (ED) and premature ejaculation (PE) are the most common sexual dysfunctions with a prevalence of ~30% and ~20%, respectively [1,2].

Key Takeaway 3

Patients were subdivided into two equal groups. Group I (80 patients) treated with daily 5-mg tadalafil for 3 months, and Group II (80 patients) treated with a placebo for the same period. After 3 months of treatment and 2 years later after cessation of tadalafil, all patients were assessed for ED and PE. The mean (SD) IELT and IIEF-5 score pre-treatment were 37 (11.24) s and 13.2 (4.2) for Group I, while in Group II they were 35.98 (10.8) s and 13.12 (4.11), respectively. After 3 months of treatment, the mean (SD) IELT in Group I showed a highly significant improvement from 37 (11.24) s to 120.5 (47.37) s (P < 0.001) but Group II showed no significant improvement from baseline to [39.43 (13.6) s; P > 0.05].

Oral Administration

For the IIEF-5 score, there was a highly significant improvement from baseline to 20.45 (4.5) in Group I (P < 0.001), while there was no significant difference in Group II from baseline to [15 (4.84); P > 0.05]. At 2 years after cessation of tadalafil, there was statistically significant improvement in the IELT and IIEF-5 from baseline to endpoint . Oral daily 5-mg tadalafil was effective, tolerable, and safe treatment for patients with ED and PE. Long-term follow-up at 2 years confirmed the persistence of a significant improvement for both ED and PE. Abbreviations: ED: erectile dysfunction; IIEF-5: five-item version of the International Index of Erectile Function questionnaire; IELT: intravaginal ejaculatory latency time; OAD: once-daily; PDE5i: phosphodiesterase-5 inhibitors; PE: premature ejaculation; PRN: pro re nata Erectile dysfunction (ED) and premature ejaculation (PE) are the most common sexual dysfunctions with a prevalence of ~30% and ~20%, respectively [1,2]. ED is a failure to accomplish and maintain an adequate erection to reach satisfaction with sexual intercourse for the last 6 months, while PE is defined as an early ejaculation within ~1 min with minimal sexual excitation just after intravaginal penetration with involuntary control that has occurred for ≥6 months in all or almost all sexual activities, leading to anxiety and depression [3]. Sexual dysfunction includes ejaculatory and orgasmic disorders, ejaculatory disorders include PE and retarded ejaculation (RE), but orgasmic disorders include anorgasmia and hypo-orgasmia. PE is classified into primary or lifelong and secondary or acquired [3]. Organic factors are the commonest predictors for acquired PE, such as prostatitis [4] and endocrine disorders [5,6]. Still, routine hormonal testing should only be directed to the patient’s complaints and risk factors with specific findings from history or physical examination [7]. Every man with PE should be adequately screened for ED, and where present, this should be addressed first. Men with ED can have performance anxiety, which may also favour PE. Accordingly, treating men with ED with ED medications improves erections and ejaculatory latency times (ELTs) [7,8]. PE co-exists with ED in ~30% of patients, mainly secondary PE. However, the specific phenotype of ED-PE men has never been systematically investigated. The five-item version of the International Index of Erectile Function (IIEF-5) questionnaire and intravaginal ELT (IELT) is used to evaluate ED and PE, respectively.

Condition Recommendation Notes
Nitrate use Do not use concurrently Risk of severe hypotension
Severe liver impairment Consult doctor before use Adjusted dosing may be necessary
Heart conditions Caution; consult healthcare provider Especially for unstable angina
Retinitis pigmentosa Use with caution Eye health considerations
Hypotension (<90/50 mmHg) Avoid use Blood pressure management

The IELT has higher sensitivity and specificity for the evaluation of PE [9].

Product Dosage Quantity + Bonus Price
Cialis Soft Tabs20mg20 + 2 Pills66.98€ 63.79€
Cialis Generic2.5mg120 + 6 Pills128.93€ 122.79€
Cialis Black80mg120 + 8 Pills264.77€ 252.16€
Cialis Super Active20mg60 + 8 Pills230.32€ 219.35€
Cialis Generic10mg60 + 6 Pills105.81€ 100.77€
Cialis Original20mg92 + 4 Pills377.99€ 359.99€
Cialis Generic20mg120 + 8 Pills188.15€ 179.19€
Cialis Professional40mg60 + 2 Pills262.32€ 249.83€
Cialis Professional20mg120 + 4 Pills291.68€ 277.79€
Cialis Professional40mg120 + 4 Pills436.68€ 415.89€
Cialis Professional20mg90 + 2 Pills241.49€ 229.99€
Cialis Professional40mg270 + 6 Pills898.37€ 855.59€
Cialis Generic10mg20 Pills48.23€ 45.93€
Cialis Generic2.5mg180 + 10 Pills154.86€ 147.49€
Cialis Super Active20mg10 Pills55.64€ 52.99€
Cialis Professional20mg20 Pills78.33€ 74.60€
Cialis Generic5mg60 + 4 Pills86.02€ 81.92€

There are many modalities for PE treatment, the most commonly used are behavioural and pharmacological therapy, but behavioural therapy is inefficient for many couples. Although many drugs are used for PE, serotonin reuptake inhibitors are the most common drugs used in PE. Other medications like topical anaesthesia or opioid agonists, like tramadol, are less commonly used [10].

  • Typical side effects of 5 mg Cialis include headache and muscle pain.
  • Rare side effects include vision changes and allergic reactions.
  • Cialis may interact with certain blood pressure medications.
  • Always consult a doctor before starting Cialis.
  • 5 mg is considered a low, safe starting dose.
  • Regular monitoring can ensure safe use.
  • Cialis is effective for men with diabetes-related ED.
  • It is important to stay hydrated while taking Cialis.
  • Patients should avoid combining Cialis with recreational drugs.
  • The medication is not for use in women or children.
  • Cialis does not protect against sexually transmitted infections.
  • The safety of Cialis has been established in many clinical trials.

Tadalafil with once-daily (OAD) and on-demand [pro re nata (PRN)] dose regimens is sufficient for treating ED.

Adverse Effects

(We have a comparison of Cialis/Tadalafil vs Viagra/Sildenafil here.) For patients dealing with an enlarged prostate, it’s important to understand that any erectile benefits from a low-dose daily Tadalafil pill will be modest. While it may help manage symptoms of BPH and mild ED, most patients will benefit from exploring the full range of treatment options so that expectations remain realistic and long-term outcomes are optimized. At Georgia Urology, your options run the gamut – from pharmaceutical therapies and minimally invasive procedures that take just a few minutes to more extensive surgical interventions when appropriate. We’ve also recently opened a state-of-the-art IR center specializing in Prostatic Artery Embolization (PAE), one of the most promising non-surgical treatments for an enlarged prostate. The best way to make informed decisions is by consulting with a men’s health urologist who can tailor a plan to your specific needs.

Are you currently using Tadalafil (Cialis, Adcirca, and others)?

Modern urology has never been as advanced as it is today, with new procedures and options for virtually every man. Contact us and schedule an appointment to learn more. To evaluate the safety and effectiveness of daily 5-mg tadalafil treatment for men who have erectile dysfunction (ED) and premature ejaculation (PE), and to assess the long-term follow-up for ED and PE improvement persistence years after the cessation of medication. A prospective, single-blind, randomised study included 160 patients with ED and PE. All were evaluated using the International Index of Erectile Function (IIEF-5) questionnaire to evaluate ED and intravaginal ejaculatory latency time (IELT) for PE. Other studies reported that the tadalafil cheap cialis soft tabs OAD dose regimen is better, and more sexual satisfaction occurred than PRN [11,12].

What special dietary instructions should I follow?

Data are presented as the mean ± standard deviation (SD); Continuous variables in comparable groups were compared by the Student’s t-test (two-tailed). In the intention-to-treat (ITT) analysis, all randomised patients were included in their original group irrespective of their compliance with treatment or loss to follow-up. Tadalafil, which is commonly used in the treatment of ED, has been recently investigated in some studies for treating PE, and most of these studies reported a significant improvement [13–15]. There were no data in the literature about long-term follow-up results of tadalafil on the improvement of PE. The present study evaluated the efficacy of daily 5-mg tadalafil treatment vs placebo for 3 months on the erectile function (assessed using the IIEF-5) and ejaculation time (IELT) in patients with ED and PE. In addition, we investigated whether there was a significant improvement in the IIEF-5 and IELT after the stoppage of tadalafil for a long time.

Bottom line

The five-item version of the International Index of Erectile Function (IIEF-5) questionnaire and intravaginal ELT (IELT) is used to evaluate ED and PE, respectively. The IELT has higher sensitivity and specificity for the evaluation of PE [9]. There are many modalities for PE treatment, the most commonly used are behavioural and pharmacological therapy, but behavioural therapy is inefficient for many couples. Although many drugs are used for PE, serotonin reuptake inhibitors are the most common drugs used in PE. Other medications like topical anaesthesia or opioid agonists, like tramadol, are less commonly used [10].

Does Cialis increase the size of a man’s penis?

Tadalafil with once-daily (OAD) and on-demand [pro re nata (PRN)] dose regimens is sufficient for treating ED. Other studies reported that the tadalafil cheap cialis soft tabs OAD dose regimen is better, and more sexual satisfaction occurred than PRN [11,12]. Tadalafil, which is commonly used in the treatment of ED, has been recently investigated in some studies for treating PE, and most of these studies reported a significant improvement [13–15]. There were no data in the literature about long-term follow-up results of tadalafil on the improvement of PE. The present study evaluated the efficacy of daily 5-mg tadalafil treatment vs placebo for 3 months on the erectile function (assessed using the IIEF-5) and ejaculation time (IELT) in patients with ED and PE. A prospective, single-blind, randomised study comparing the safety and efficacy of 5-mg tadalafil continuous daily dosing for 3 months compared with placebo for ED with PE and assessment of persistence of improvement after 2 years from the cessation of tadalafil. This study was conducted on 160 patients attending the urology outpatient clinic, Benha University Hospital, and Al-Azhar University Hospital from April 2018 to April 2019, including men aged 18–65 years who had ED and lifelong PE for the last 6 months of a continuous marriage relationship.

Patients and methods

ED is a failure to accomplish and maintain an adequate erection to reach satisfaction with sexual intercourse for the last 6 months, while PE is defined as an early ejaculation within ~1 min with minimal sexual excitation just after intravaginal penetration with involuntary control that has occurred for ≥6 months in all or almost all sexual activities, leading to anxiety and depression [3]. Sexual dysfunction includes ejaculatory and orgasmic disorders, ejaculatory disorders include PE and retarded ejaculation (RE), but orgasmic disorders include anorgasmia and hypo-orgasmia. PE is classified into primary or lifelong and secondary or acquired [3]. Organic factors are the commonest predictors for acquired PE, such as prostatitis [4] and endocrine disorders [5,6]. Still, routine hormonal testing should only be directed to the patient’s complaints and risk factors with specific findings from history or physical examination [7].

Mild side effects

Every man with PE should be adequately screened for ED, and where present, this should be addressed first. Men with ED can have performance anxiety, which may also favour PE. Accordingly, treating men with ED with ED medications improves erections and ejaculatory latency times (ELTs) [7,8]. PE co-exists with ED in ~30% of patients, mainly secondary PE. However, the specific phenotype of ED-PE men has never been systematically investigated. We excluded from our study patients with a neurogenic disorder, parkinsonism, diabetes mellitus, active Urinary tract infection (UTI), chronic prostatitis, chronic renal failure, Peyronie’s disease, and endocrine disorders, including low testosterone, hyperprolactinaemia, and thyroid dysfunction, patients taking medications for PE and drugs affecting erectile function. Written informed consent was obtained from all patients enrolled in this study, which the local ethics committee approved. The sample size was calculated using the EPI info 2000 statistical package (Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA). The null hypothesis of the study was that tadalafil has no treatment effect relative to placebo. A statistical significance at P < 0.05 was required for the two co-primary endpoints (IIEF-5, IELF) to reject the null hypothesis, and a sample size of 160 patients (80 placebo and 80 tadalafil) was calculated to give 90% power to detect a significant treatment effect. Patients were subdivided into two equal groups and randomised using the secure envelope method.

  • Not a cure for erectile dysfunction; treats symptoms while taken.
  • Can be used safely long-term under medical supervision.
  • May interact with certain antibiotics and antifungal medications.
  • Men over 65 may be more sensitive to side effects.
  • Use cautiously with medications for high blood pressure.
  • Recreational use without medical need is dangerous and illegal.
  • Counterfeit versions sold online often contain incorrect dosages.
  • Report any chest pain, dizziness, or nausea to your doctor.
  • Combining with other ED treatments is not recommended.
  • Allows for less frequent dosing compared to sildenafil (Viagra).

Group I included 80 patients treated with a daily 5-mg tadalafil oral tablet for 3 months, and Group II included 80 patients treated with a placebo for the same period. The tadalafil group were followed up for 2 years after cessation of tadalafil, but five patients were lost during follow-up, and so 75 patients were assessed at the end of 2 years. Full medical and sexual history was taken with the history of current medications, a complete physical and genital examination was performed, and all patients were evaluated using the IIEF-5 to evaluate ED and IELT for PE [16] before and after treatment and at the end of the 2-year follow up. The IIEF is a multidimensional validated questionnaire including 15 questions in the five domains of sexual function (erectile and orgasmic functions, sexual desire, satisfaction with intercourse, and overall sexual satisfaction). More recently, to simplify the IIEF, an abridged five-items version the IIEF-5 has been used as a diagnostic tool for ED and evaluation of treatment. It consists of only five questions, and each IIEF-5 item is scored on a 5-point ordinal scale where lower values represent an impaired sexual function. According to this scale, ED is classified into three grades based on IIEF-5 scores: severe ED (score: 1–7), moderate ED (8–11), and mild ED (12–21) [17]. The IELT was defined as the time from intravaginal intromission to intravaginal ejaculation.

General Dose Information

The tadalafil group were followed up for 2 years after cessation of tadalafil, but five patients were lost during follow-up, and so 75 patients were assessed at the end of 2 years. Full medical and sexual history was taken with the history of current medications, a complete physical and genital examination was performed, and all patients were evaluated using the IIEF-5 to evaluate ED and IELT for PE [16] before and after treatment and at the end of the 2-year follow up. The IIEF is a multidimensional validated questionnaire including 15 questions in the five domains of sexual function (erectile and orgasmic functions, sexual desire, satisfaction with intercourse, and overall sexual satisfaction). More recently, to simplify the IIEF, an abridged five-items version the IIEF-5 has been used as a diagnostic tool for ED and evaluation of treatment. It consists of only five questions, and each IIEF-5 item is scored on a 5-point ordinal scale where lower values represent an impaired sexual function.

US Brand Name

According to this scale, ED is classified into three grades based on IIEF-5 scores: severe ED (score: 1–7), moderate ED (8–11), and mild ED (12–21) [17]. The IELT was defined as the time from intravaginal intromission to intravaginal ejaculation. Female partners were provided with a stopwatch and instructions on how to record and measure the IELT. It can be used as an integrated measurement of the partners, and that it was a simple and objective screening indicator for diagnosing self-reporting PE [18]. The collected data were revised, organised, tabulated, and statistically analysed using the Statistical Package for the Social Sciences (SPSS®) version 25.0 (IBM Corp., Armonk, NY, USA). Female partners were provided with a stopwatch and instructions on how to record and measure the IELT. It can be used as an integrated measurement of the partners, and that it was a simple and objective screening indicator for diagnosing self-reporting PE [18].

Storage Condition Recommended Temperature Additional Tips
Room Temperature 20-25°C (68-77°F) Keep away from moisture
Protect from Light Yes Store in a dry, cool place
Keep Out of Reach Yes Keep out of children's reach
Expiry Date Check regularly Do not use expired medication
Packaging Original packaging Prevents contamination

The collected data were revised, organised, tabulated, and statistically analysed using the Statistical Package for the Social Sciences (SPSS®) version 25.0 (IBM Corp., Armonk, NY, USA). Data are presented as the mean ± standard deviation (SD); Continuous variables in comparable groups were compared by the Student’s t-test (two-tailed).

Using Cialis With Food

In addition, we investigated whether there was a significant improvement in the IIEF-5 and IELT after the stoppage of tadalafil for a long time. A prospective, single-blind, randomised study comparing the safety and efficacy of 5-mg tadalafil continuous daily dosing for 3 months compared with placebo for ED with PE and assessment of persistence of improvement after 2 years from the cessation of tadalafil. This study was conducted on 160 patients attending the urology outpatient clinic, Benha University Hospital, and Al-Azhar University Hospital from April 2018 to April 2019, including men aged 18–65 years who had ED and lifelong PE for the last 6 months of a continuous marriage relationship. We excluded from our study patients with a neurogenic disorder, parkinsonism, diabetes mellitus, active Urinary tract infection (UTI), chronic prostatitis, chronic renal failure, Peyronie’s disease, and endocrine disorders, including low testosterone, hyperprolactinaemia, and thyroid dysfunction, patients taking medications for PE and drugs affecting erectile function. Written informed consent was obtained from all patients enrolled in this study, which the local ethics committee approved.

Alternatives for benign prostatic hyperplasia (BPH)

The sample size was calculated using the EPI info 2000 statistical package (Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA). The null hypothesis of the study was that tadalafil has no treatment effect relative to placebo. A statistical significance at P < 0.05 was required for the two co-primary endpoints (IIEF-5, IELF) to reject the null hypothesis, and a sample size of 160 patients (80 placebo and 80 tadalafil) was calculated to give 90% power to detect a significant treatment effect. Patients were subdivided into two equal groups and randomised using the secure envelope method. Group I included 80 patients treated with a daily 5-mg tadalafil oral tablet for 3 months, and Group II included 80 patients treated with a placebo for the same period. In the intention-to-treat (ITT) analysis, all randomised patients were included in their original group irrespective of their compliance with treatment or loss to follow-up.

Site Operator

Fabienne Heyne
[email protected]

Corporate Design

Silvio Ketterer Visuelle Gestaltung
www.silvioketterer.ch

Website Programming

RHOdesign
www.rhodesign.ch

Photography

Angelika Annen
www.angelikaannen.ch